Stephens Consulting’s Gilead Sciences GILD Stock Holding History

Stephens Consulting’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$354K	Hold	2,881	–	–	0.11%	47
2025 Q3	$320K	Sell	2,881 -177	-6%	-$20.1K	0.11%	49
2025 Q2	$339K	Buy	3,058 +1,627	+114%	+$173K	0.08%	80
2025 Q1	$160K	Buy	1,431 +1,091	+321%	+$113K	0.04%	105
2024 Q4	$31.4K	Buy	340 +260	+325%	+$23.4K	0.01%	224
2024 Q3	$6.71K	Hold	80	–	–	﹤0.01%	374
2024 Q2	$5.49K	Hold	80	–	–	﹤0.01%	401
2024 Q1	$5.86K	Hold	80	–	–	﹤0.01%	351
2023 Q4	$6.48K	Hold	80	–	–	﹤0.01%	353
2023 Q3	$6K	Hold	80	–	–	﹤0.01%	360
2023 Q2	$6.17K	Hold	80	–	–	﹤0.01%	360
2023 Q1	$6.64K	Hold	80	–	–	﹤0.01%	370
2022 Q4	$6.87K	Hold	80	–	–	﹤0.01%	345
2022 Q3	$4.93K	Hold	80	–	–	﹤0.01%	408
2022 Q2	$4.95K	Hold	80	–	–	﹤0.01%	403
2022 Q1	$4.76K	Sell	80 -15	-16%	-$959	﹤0.01%	438
2021 Q4	$6.9K	Buy	+95	New	+$6.54K	0.01%	441

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Stephens Consulting's GILD Position: Q4 2025 in Review

Stephens Consulting held its Gilead Sciences (GILD) position steady in Q4 2025 at 2,881 shares worth $354K. The position accounts for 0.11% of the portfolio, ranked #47.

Stephens Consulting first reported a position in GILD in Q4 2021 and has held it in 17 quarters since. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

Stephens Consulting held 2,881 shares of Gilead Sciences worth $354K as of Q4 2025.
Stephens Consulting left its Gilead Sciences share count unchanged in Q4 2025.
Gilead Sciences made up 0.11% of Stephens Consulting's portfolio in Q4 2025, its #47 holding.
Stephens Consulting first reported a position in Gilead Sciences in Q4 2021 and has held it in 17 quarters since.
2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Stephens Consulting's 13F filing for Q4 2025, filed 13 Jan 2026.